
Medical Oncologist

No OPD information available
Colorectal Cancer
Testicular Cancer
Agranulocytosis
Delayed Ejaculation
Febrile Neutropenia
Non-Muscle Invasive Bladder Cancer
Orchiectomy
Prostate Cancer
Renal Cell Carcinoma (RCC)
Retrograde Ejaculation
Venous Thromboembolism (VTE)
Bladder Cancer
Breast Cancer
Cholangiocarcinoma (Bile Duct Cancer)
Deep Vein Thrombosis
Endometrial Cancer
Heart Tumor
Hypophosphatemia
Lymphofollicular Hyperplasia
Metastatic Brain Tumor
Pancreatic Cancer
Pneumonia
Teratoma of the Mediastinum
Urothelial Cancer
Ben Tran is a male medical professional who helps patients with various health conditions like cancer, blood disorders, and other serious illnesses. He specializes in treating different types of cancers such as colorectal cancer, testicular cancer, prostate cancer, and more. Ben Tran also deals with conditions like delayed ejaculation, pneumonia, and heart tumors.
Patients trust Ben Tran because he communicates well with them, explaining their conditions and treatment options in a clear and caring manner. He stays updated with the latest medical knowledge and research to provide the best care possible to his patients.
Ben Tran works closely with other medical professionals, collaborating to ensure patients receive comprehensive and effective treatment. He has published research in medical journals and has conducted clinical trials to advance the understanding and treatment of various diseases.
Ben Tran's work has positively impacted many patients' lives by providing them with expert care and support during challenging times. His dedication to improving patient outcomes and quality of life is evident in his compassionate approach to healthcare.
One of Ben Tran's notable publications is a clinical trial protocol for a study evaluating a new treatment for metastatic castration-resistant prostate cancer. He has also conducted clinical trials investigating the use of a drug in patients with advanced solid tumors.
In summary, Ben Tran is a skilled and compassionate medical professional who is dedicated to providing high-quality care to his patients, staying updated with the latest medical advancements, collaborating with colleagues, and conducting research to improve treatment options for various health conditions.
Enrollment Status: Completed
Published: March 27, 2025
Intervention Type: Drug
Study Drug: TAS-120
Study Phase: Phase 1/Phase 2
